No Data
This Bio-Techne Insider Reduced Their Stake By 19%
KeyBanc Maintains Bio-Techne(TECH.US) With Buy Rating, Maintains Target Price $80
KeyBanc analyst Paul Knight maintains $Bio-Techne(TECH.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success rate of 43.1% and a total ave
Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)?
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
Express News | Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to Serve as Independent Chairman of the Board of Directors